logo
  Home | Contact us | Browse | Quick Search by UniProtKB ID, Keyword, PDBID

Menu:

Latest news:

Sep. 10, 2014:
A total of 174 experimentally verified S-nitrosylation sites on 94 S-nitrosylated proteins from individualized human colorectal cancer tissues using a label-free quantitation strategy.

Read more...


Protein Name: Thioredoxin

UniprotKB/SwissProt ID: THIO_HUMAN (P10599)

Gene Name: TXN

Synonyms: TRDX, TRX, TRX1

Organism: Homo sapiens (Human).

Function: Participates in various redox reactions through the reversible oxidation of its active center dithiol to a disulfide and catalyzes dithiol-disulfide exchange reactions. Plays a role in the reversible S-nitrosylation of cysteine residues in target proteins, and thereby contributes to the response to intracellular nitric oxide. Nitrosylates the active site Cys of CASP3 in response to nitric oxide (NO), and thereby inhibits caspase-3 activity. Induces the FOS/JUN AP-1 DNA-binding activity in ionizing radiation (IR) cells through its oxidation/reduction status and stimulates AP-1 transcriptional activity. ADF augments the expression of the interleukin-2 receptor TAC (IL2R/P55).

Other Modifications: View all modification sites in dbPTM

Protein Subcellular Localization: Nucleus. Cytoplasm. Secreted. Note=Secreted by a leaderless secretory pathway. Predominantly in the cytoplasm in non irradiated cells. Radiation induces translocation of TRX from the cytoplasm to the nucleus.

PDB :
( If your security settings prevent Jmol from running, please register http://140.138.144.145/ as a safe location in your Java settings. )

Graphical Visualization of S-nitrosylation Sites:
Overview of Protein S-nitrosylation Sites with Functional and Structural Information
InterPro ID Domain
IPR006662
IPR012335
IPR012336
IPR013766
IPR015467

3D Structure Databases:
3D structure databases
EntryMethodResolution (A)ChainPositionsView
1AIU X-ray 2.00 A A1-105Link
1AUC X-ray 2.10 A A1-105Link
1CQG NMR - A1-105Link
1CQH NMR - A1-105Link
1ERT X-ray 1.70 A A1-105Link
1ERU X-ray 2.10 A A1-105Link
1ERV X-ray 1.65 A A1-105Link
1ERW X-ray 1.80 A A1-105Link
1M7T NMR - A1-65Link
1MDI NMR - A2-104Link
1MDJ NMR - A2-104Link
1MDK NMR - A2-104Link
1TRS NMR - A1-105Link
1TRU NMR - A1-105Link
1TRV NMR - A1-105Link
1TRW NMR - A1-105Link
1W1C Model - C1-105Link
1W1E Model - C1-105Link
2HSH X-ray 1.35 A A1-105Link
2HXK X-ray 1.65 A A/B/C1-105Link
2IFQ X-ray 1.20 A A/B/C1-105Link
2IIY X-ray 1.70 A A1-105Link
3E3E X-ray 2.01 A A/B1-105Link
3KD0 X-ray 1.70 A A1-105Link
3M9J X-ray 1.10 A A/B1-105Link
3M9K X-ray 1.50 A A/B1-105Link
3QFA X-ray 2.20 A C/D2-105Link
3QFB X-ray 2.60 A C/D2-105Link
3TRX NMR - A1-105Link
4LL1 X-ray 2.00 A B/D1-105Link
4LL4 X-ray 2.70 A B/D1-105Link
4OO4 X-ray 0.97 A A/B1-105Link
4OO5 X-ray 1.54 A A1-105Link
4TRX NMR - A1-105Link

The S-nitrosylation sites of THIO_HUMAN

No. Position S-nitrosylated Peptide Secondary Structure of S-nitrosylated Peptide Solvent Accessibility of nitrosylated Site Substrate Motifs PubMed ID Experiment
162VIFLEVDVDD C QDVASECEVK CEEEEEECCC C HHHHHHCCCC 3.01%HC0722178444-
262VIFLEVDVDD C QDVASECEVK CEEEEEECCC C HHHHHHCCCC 3.01%HC0717260951-
369VDDCQDVASE C EVKCMPTFQF CCCCHHHHHH C CCCCCCEEEE 7.25%HC0622178444-
469VDDCQDVASE C EVKCMPTFQF CCCCHHHHHH C CCCCCCEEEE 7.25%HC0615688001-
569VDDCQDVASE C EVKCMPTFQF CCCCHHHHHH C CCCCCCEEEE 7.25%HC0616220319-
669VDDCQDVASE C EVKCMPTFQF CCCCHHHHHH C CCCCCCEEEE 7.25%HC0617260951-
769VDDCQDVASE C EVKCMPTFQF CCCCHHHHHH C CCCCCCEEEE 7.25%HC0618497292-
869VDDCQDVASE C EVKCMPTFQF CCCCHHHHHH C CCCCCCEEEE 7.25%HC0618544525-
973QDVASECEVK C MPTFQFFKKG HHHHHHCCCC C CCEEEEEECC 4.82%HC0222178444-
1073QDVASECEVK C MPTFQFFKKG HHHHHHCCCC C CCEEEEEECC 4.82%HC0225040305in vivo
1173QDVASECEVK C MPTFQFFKKG HHHHHHCCCC C CCEEEEEECC 4.82%HC0216408020-
1273QDVASECEVK C MPTFQFFKKG HHHHHHCCCC C CCEEEEEECC 4.82%HC0217260951-
1373QDVASECEVK C MPTFQFFKKG HHHHHHCCCC C CCEEEEEECC 4.82%HC0217606900-
1473QDVASECEVK C MPTFQFFKKG HHHHHHCCCC C CCEEEEEECC 4.82%HC0218497292-
1573QDVASECEVK C MPTFQFFKKG HHHHHHCCCC C CCEEEEEECC 4.82%HC0218544525-
1673QDVASECEVK C MPTFQFFKKG HHHHHHCCCC C CCEEEEEECC 4.82%HC0218635375-
1773QDVASECEVK C MPTFQFFKKG HHHHHHCCCC C CCEEEEEECC 4.82%HC0219483679in vivo